Hemophilia and other inherited blood coagulation disorders in Poland;Hemofilia i pokrewne skazy krwotoczne w Polsce

Polskie Archiwum Medycyny Wewnetrznej

Volumn 112, Issue 4, 2004, Pages 1197-1202

  Windyga, Jerzy ^a   Łopaciuk, Stanisław ^a   Stefańska, Ewa ^a   Klukowska, Anna ^b  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^b Katedra i Klinika Pediatr i Nefrol   (Poland)

Author keywords

Blood coagulation disorders; Hemophilia; Poland

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CHILD; HEMOPHILIA A; HEMOPHILIA B; HUMAN; INFANT; INHERITANCE; MAJOR CLINICAL STUDY; POLAND; PREVALENCE; REGISTER; VON WILLEBRAND DISEASE;

EID: 10844221416     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Niewiarowski S., Cetnarowicz H., Latałło Z., Sabliński J.: Badania nad hemofilia̧ w Polsce. I. Wyniki badań klinicznych i laboratoryjnych w 111 przypadkach. Pol. Tyg. Lek., 1958, 13, 2101.
2. Łopaciuk S., Cetnarowicz H., Dyszy-Laube B., Burzyńska- Klukowska A.: Hemofilia i pokrewne skazy krwotoczne w Polsce. Pol. Tyg. Lek., 1981, 36, 1007.
3. Łopaciuk S.: Badania układu krzepniȩcia krwi. W: Diagnostyka laboratoryjna w hematologii (red. S. Pawelski). PZWL Warszawa, 1990, 193.
4. Larsson S.A., Nilsson I.M., Blombäck M.: Current status of Swedish hemophiliacs. I. A demographic survey. Acta. Med. Scand., 1982, 212, 195.
5. Pilot study of hemophilia treatment in the United States. National Blood Resource Program, National Institute of Health, Bethesda, Maryland, 1972, 3, 44.
6. Bauduer F., Degioanni A., Ducout C., Scrbans C., Dutour O.: Distribution of haemophilia in the French Basque country. Haemophilia, 2002, 8, 735.
7. Koumbarelis E., Rosendaal F.R., Gialeraki A.: Epidemiology of haemophilia in Greece: an overview. Thromb. Haemost., 1994, 72, 808.
8. Ludlam C.A., Lee R.J., Prescott R.J.: Haemophilia in central Scotland 1980-1994. I. Demographic characteristics, hospital admissions and causes of death. Haemophilia, 2000, 6, 494.
9. Allain J.P: Management of haemophilia in France. Thromb. Haemost., 1976, 35, 353.
10. Bolton-Maggs PH.B., Pasi J.K.: Haemophilias A and B. Lancet, 2003, 361, 1801.
11. Rizza C.R., Spooner R.J.D., Giangrande P.L.F.: Treatment of haemophilia in United Kingdom 1981-1996. Haemophilia, 2001, 7, 349.
12. Sultan Y.: Prevalence of inhibitors in a population of 3435 hemophilia patients in France. French Hemophilia Study Group. Thromb. Haemost., 1992, 67, 600.
13. Rosendaal F.R., Nieuwenhuis H.K., van den Berg H.M.: A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in the Netherlands. Dutch Hemophilia Study Group. Blood, 1993, 81, 2180.
14. Lusher J.M.: Natural history of inhibitors in severe haemophilia A and B: incidence and prevalence. [w:] Inhibitors in patients with haemophilia (red.), E.C. Rodriguez-Merchan, C.A. Lee). Blackwell Science Ltd, 2002, 3.
15. nd Hemophilia Symposium Hamburg 2001 (red.) I. Scharrer, W. Schramm. Springer Verlag Berlin Heidelberg, 2003, 13.
16. Łopaciuk S.: Rozpoznawanie i leczenie choroby von Willebranda. Acta Haemat. Pol., 2003, 34 (supll. 1), 62.
17. Peyvandi F., Duga S., Akhavan S., Mannucci P.M.: Rare coagulation deficiencies. Haemophilia, 2002, 8, 308.